European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders

Lupus

Volumn 15, Issue 7, 2006, Pages 391-396

  Wiik, Allan ^a   Cervera, R ^b   Haass, M ^c   Kallenberg, C ^d   Khamashta, M ^e   Meroni, P L ^f   Piette, J C ^g   Schmitt, R ^h   Shoenfeld, Y ⁱ  

^a STATENS SERUM INSTITUT   (Denmark)

^b HOSPITAL CLÍNIC   (Spain)

^c Thermo Fisher Scientific   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f UNIVERSITY OF MILAN   (Italy)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autoantibodies; Clinical use; Early diagnosis; Guidelines; Methods; Reporting

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ALGORITHM; ARTICLE; AUTOIMMUNE DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; EUROPE; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; LABORATORY TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATIC DISEASE; SEROLOGY;

ALGORITHMS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; EUROPE; HUMANS; IMMUNOLOGIC TECHNIQUES; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; RHEUMATIC DISEASES; RHEUMATOID FACTOR; RHEUMATOLOGY;

EID: 33746621685     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2322oa     Document Type: Article

References (10)

1. Wiik A. Clinical use of serological tests for ANCA: What do the studies say? Rheum Dis Clin North Amer 2001; 27: 799-813.
2. Wiik A. Anti-nuclear antibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005; 34: 260-268.
3. Nossent HC, Rekvig OP. Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal? Arthritis Res Ther 2005; 7: 85-87.
4. Riboldi P, Gerosa M, Moroni G et al. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity 2005; 38: 39-45.
5. Wiik A, Gordon TA, Kavanaugh AF et al. Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimising the use of autoimmune serology. Arthritis Rheum (Arthritis Care & Research) 2004; 51: 291-298.
6. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
7. Visser H, Le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46: 357-365.
8. Wiik A, Lam K. On the usability of extended DOORS for education and training, quality assurance and consensus formation. The EU CANTOR project HC 4003 (HC) 2000. Deliverable D09.1, version 2.1. The European Commission, 2001.
9. Bizzaro N, Wiik A. Approriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 2004; 22: 349-355.
10. Fritzler MJ, Wiik A, Tan EM et al. A critical evaluation of enzyme immunoassay kits for detection of antinuclear antibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturer's laboratories. J Rheumatol 2003; 30: 2374-2381.